WP
RLAY icon

Woodline Partners’s Relay Therapeutics RLAY Stock Holding History

Woodline Partners’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.76M Buy
679,342
+227
+0% +$2.03K 0.03% 602
2025
Q4 		$5.75M Sell
679,115
-339,000
-33% -$2.42M 0.02% 596
2025
Q3 		$5.31M Hold
1,018,115
– – 0.03% 552
2025
Q2 		$3.52M Sell
1,018,115
-500,446
-33% -$1.49M 0.02% 621
2025
Q1 		$3.98M Buy
1,518,561
+1,241,657
+448% +$4.87M 0.03% 560
2024
Q4 		$1.14M Hold
276,904
– – 0.01% 737
2024
Q3 		$1.96M Buy
276,904
+3,288
+1% +$24.6K 0.02% 479
2024
Q2 		$1.78M Buy
273,616
+608
+0.2% +$4.15K 0.02% 429
2024
Q1 		$2.27M Buy
273,008
+23,008
+9% +$224K 0.02% 421
2023
Q4 		$2.75M Hold
250,000
– – 0.03% 363
2023
Q3 		$2.1M Hold
250,000
– – 0.02% 395
2023
Q2 		$3.14M Sell
250,000
-25,000
-9% -$311K 0.04% 367
2023
Q1 		$4.53M Sell
275,000
-56,663
-17% -$1.02M 0.06% 309
2022
Q4 		$4.96M Hold
331,663
– – 0.07% 319
2022
Q3 		$7.42M Hold
331,663
– – 0.1% 236
2022
Q2 		$5.55M Hold
331,663
– – 0.09% 245
2022
Q1 		$9.93M Buy
331,663
+76,062
+30% +$1.85M 0.16% 177
2021
Q4 		$7.85M Hold
255,601
– – 0.11% 227
2021
Q3 		$8.06M Sell
255,601
-32,956
-11% -$1.11M 0.13% 185
2021
Q2 		$10.6M Buy
288,557
+50,117
+21% +$1.65M 0.2% 131
2021
Q1 		$8.24M Sell
238,440
-54,775
-19% -$2.38M 0.18% 142
2020
Q4 		$12.2M Sell
293,215
-58,608
-17% -$2.65M 0.32% 94
2020
Q3 		$15M Buy
+351,823
New +$13.4M 0.49% 58

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Woodline Partners's RLAY Position: Q1 2026 in Review

Woodline Partners increased its Relay Therapeutics (RLAY) stake by 0.03% in Q1 2026, buying an estimated $2.03K and bringing the position to 679,342 shares worth $6.76M. The position accounts for 0.03% of the portfolio, ranked #602.

Woodline Partners first reported a position in RLAY in Q3 2020 and has held it in 23 quarters since. The position peaked at $15M in Q3 2020. 242 funds tracked by Wall St. Rank hold RLAY as of Q1 2026.

  • Woodline Partners held 679,342 shares of Relay Therapeutics worth $6.76M as of Q1 2026.
  • Woodline Partners bought 227 Relay Therapeutics shares in Q1 2026, an estimated $2.03K.
  • Relay Therapeutics made up 0.03% of Woodline Partners's portfolio in Q1 2026, its #602 holding.
  • Woodline Partners first reported a position in Relay Therapeutics in Q3 2020 and has held it in 23 quarters since.
  • Woodline Partners's Relay Therapeutics position peaked at $15M in Q3 2020.
  • 242 funds tracked by Wall St. Rank held Relay Therapeutics as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.